Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets

Go back to Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
(NASDAQ: ARLZ) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High $6.80 
Open $0.88    52 Week Low $3.10 
Day High $0.03    P/E N/A 
Day Low $0.03    EPS $0.00 
Volume      

National Health Partners, Inc. (NYSE: HPR) Delayed: 4.73 --0 (-0%)
Previous Close $4.73    52 Week High $0.28 
Open $3.62    52 Week Low $0.25 
Day High $4.73    P/E N/A 
Day Low $4.73    EPS $-0.23 
Volume 3,248       

HORIZON PHARMA (NASDAQ: HZNP) Delayed: 116.30 --0 (-0%)
Previous Close $116.30    52 Week High $23.44 
Open $19.84    52 Week Low $13.06 
Day High $116.30    P/E N/A 
Day Low $116.30    EPS $-0.96 
Volume 283,408